Black Diamond Therapeutics (BDTX) Insider Trading & Ownership $2.34 -0.16 (-6.40%) (As of 05:30 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Black Diamond Therapeutics (NASDAQ:BDTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.87%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$22.55 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$167,500.00 Get BDTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Black Diamond Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BDTX Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Black Diamond Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/17/2023Growth N V BiotechMajor ShareholderBuy400,000$2.34$936,000.00 7/5/2023Ali BehbahaniDirectorBuy1,000,000$5.00$5,000,000.00 6/30/2023Growth N V BiotechMajor ShareholderBuy1,000,000$5.00$5,000,000.00 6/27/2023David M EpsteinInsiderSell25,000$6.70$167,500.00 6/27/2023Growth N V BiotechMajor ShareholderBuy1,740,000$5.49$9,552,600.00 10/27/2022Growth N V BiotechMajor ShareholderBuy191,678$1.87$358,437.86 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/21/2022Growth N V BiotechMajor ShareholderBuy87,850$1.51$132,653.50 10/19/2022Growth N V BiotechMajor ShareholderBuy77,689$1.32$102,549.48 6/29/2022Fang NiInsiderBuy25,000$2.44$61,000.00 4/27/2022Growth N V BiotechMajor ShareholderBuy150,000$2.66$399,000.00 4/18/2022Growth N V BiotechMajor ShareholderBuy150,000$3.29$493,500.00 4/12/2022Growth N V BiotechMajor ShareholderBuy150,000$3.42$513,000.00 (Data available from 1/1/2013 forward) BDTX Insider Trading Activity - Frequently Asked Questions Who is on Black Diamond Therapeutics's Insider Roster? The list of insiders at Black Diamond Therapeutics includes Ali Behbahani, David M Epstein, Fang Ni, and Growth N V Biotech. Learn more on insiders at BDTX. What percentage of Black Diamond Therapeutics stock is owned by insiders? 8.87% of Black Diamond Therapeutics stock is owned by insiders. Learn more on BDTX's insider holdings. Which Black Diamond Therapeutics insiders have been buying company stock? The following insiders have purchased BDTX shares in the last 24 months: Ali Behbahani ($5,000,000.00), and Growth N V Biotech ($15,488,600.00). How much insider buying is happening at Black Diamond Therapeutics? Insiders have purchased a total of 4,140,000 BDTX shares in the last 24 months for a total of $20,488,600.00 bought. Which Black Diamond Therapeutics insiders have been selling company stock? The following insider sold BDTX shares in the last 24 months: David M Epstein ($167,500.00). How much insider selling is happening at Black Diamond Therapeutics? Insiders have sold a total of 25,000 Black Diamond Therapeutics shares in the last 24 months for a total of $167,500.00 sold. Black Diamond Therapeutics Key ExecutivesDr. Mark A. Velleca M.D. (Age 60)Ph.D., CEO, President & Chairman Compensation: $795.98kDr. David M. Epstein Ph.D. (Age 65)Co-Founder & Director Compensation: $969.69kDr. Fang Ni Pharm.D. (Age 37)CFO, Principal Financial Officer and Chief Business Officer Compensation: $665.98kDr. Sergey Yurasov M.D. (Age 55)Ph.D., Chief Medical Officer Compensation: $718.92kDr. Elizabeth Buck Ph.D. (Age 49)Co-Founder & Chief Scientific Officer Compensation: $340.47kMr. Brent Hatzis-Schoch Esq. (Age 59)J.D., COO & General Counsel Compensation: $683.29kMs. Elizabeth L. Montgomery (Age 52)Chief People Officer Ms. Melanie Morrison (Age 49)Chief Development Officer Ms. Erika Jones (Age 39)Senior VP of Finance & Corporate Controller More Insider Trading Tools from MarketBeat Related Companies Phathom Pharmaceuticals Insider Ownership Tourmaline Bio Insider Ownership ProKidney Insider Ownership Ginkgo Bioworks Insider Ownership Annexon Insider Ownership Astria Therapeutics Insider Ownership Humacyte Insider Ownership AnaptysBio Insider Ownership Mereo BioPharma Group Insider Ownership CorMedix Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:BDTX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDTX Stock Alerts